51. Vaginal Ovule Loaded with Bismuth Lipophilic Nanoparticles and Cetylpyridinium Chloride Inhibits Human Cervical Carcinoma and Candida albicans Growth
- Author
-
Claudio Cabral-Romero, Rene Hernández-Delgadillo, Jesús Alejandro Torres-Betancourt, Claudia María García-Cuellar, Yesennia Sánchez-Pérez, Juan Manuel Solis-Soto, Irene Meester, Nayely Pineda-Aguilar, Sergio Eduardo Nakagoshi-Cepeda, Juan Valerio Cauich-Rodríguez, and María Argelia Akemi Nakagoshi-Cepeda
- Subjects
antitumor and antimycotic activity ,bismuth lipophilic nanoparticles (BisBAL NPs) ,cetylpyridinium chloride ,human cervical carcinoma ,topical treatment ,vaginal ovule ,Biotechnology ,TP248.13-248.65 ,Medicine (General) ,R5-920 - Abstract
Bismuth lipophilic nanoparticles (BisBAL NPs) and cetylpyridinium chloride (CPC) are antineoplastic and antimicrobial in vitro. As a next pre-clinical step, a clinically viable dosage form for vaginal application was developed. Compendial pharmacopeial tests (mass uniformity, disintegration, and compressive mechanics) and inductively coupled plasma optical emission spectroscopy were conducted on in-house developed glycerinated gelatin (60:15 v/w) vaginal ovules containing BisBAL NP-CPC. The antimycotic activity of BisBAL NP-CPC vaginal ovules was analyzed using disk diffusion and cell viability XTT assays. The antitumor properties of BisBAL NP-CPC vaginal ovules were assessed by cell viability MTT tests. BisBAL NP-CPC and drug-free vaginal ovules deposited into ex vivo porcine vaginas disaggregated without signs of adverse cytotoxicity within the timespan of clinical efficacy. BisBAL NP-CPC vaginal ovules demonstrated antifungal efficacy comparable to miconazole: C. albicans growth inhibition haloes in diffusion tests were 23 ± 0.968 mm (n = 3) for BisBAL NP-CPC and 20.35 ± 0.899 mm (n = 3) for miconazole. Likewise, BisBAL NP-CPC vaginal ovules reduced HeLa cell growth by 81%, outperforming the clinical reference of 500 μM 5-fluouracil, which induced a 70% growth inhibition. BisBAL NP-CPC incorporated into glycerinated gelatin vaginal ovules constitute an innovative drug delivery system for topical antimycotic and anti-cervical carcinoma treatments.
- Published
- 2024
- Full Text
- View/download PDF